The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: Implications for antiangiogenic strategies

Khalid Bajou, Véronique Masson, Robert D. Gerard, Petra M. Schmitt, Valérie Albert, Michael Praus, Leif R. Lund, Thomas L. Frandsen, Nils Brunner, Keld Dano, Norbert E. Fusenig, Ulrich Weidle, Geert Carmeliet, David Loskutoff, Desiré Collen, Peter Carmeliet, Jean Michel Foidart, Agnès Noël